Trial intelligence / Profile preview

Calcitriol in Nondiabetic CKD

NCT01512862Phase 4Unknown

Sponsor
Seoul National University Hospital
Start
Jan 2012
Primary completion
Dec 2012
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in chronic kidney disease (CKD) comparing Calcitriol with Placebo (2 arms). Primary endpoint: Changes in proteinuria at 12 months. Status: unknown.

02

Drugs

calcitriol
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT01512862.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01512862.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call